Bahl & Gaynor’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $613M | Sell |
666,129
-121,251
| -15% | -$123M | 3.09% | 4 |
|
|
2025
Q4 | $846M | Sell |
787,380
-16,600
| -2% | -$15.9M | 4.28% | 3 |
|
|
2025
Q3 | $613M | Sell |
803,980
-27,509
| -3% | -$20.5M | 3.05% | 6 |
|
|
2025
Q2 | $648M | Sell |
831,489
-12,911
| -2% | -$10M | 3.28% | 5 |
|
|
2025
Q1 | $697M | Sell |
844,400
-7,490
| -0.9% | -$6.23M | 3.55% | 3 |
|
|
2024
Q4 | $658M | Sell |
851,890
-11,708
| -1% | -$9.69M | 3.48% | 4 |
|
|
2024
Q3 | $765M | Sell |
863,598
-1,759
| -0.2% | -$1.58M | 3.94% | 2 |
|
|
2024
Q2 | $783M | Sell |
865,357
-12,442
| -1% | -$9.95M | 4.38% | 2 |
|
|
2024
Q1 | $683M | Sell |
877,799
-18,770
| -2% | -$13.4M | 3.8% | 2 |
|
|
2023
Q4 | $523M | Sell |
896,569
-38,504
| -4% | -$22.5M | 3.14% | 4 |
|
|
2023
Q3 | $502M | Sell |
935,073
-28,074
| -3% | -$14.5M | 3.21% | 4 |
|
|
2023
Q2 | $452M | Sell |
963,147
-145,114
| -13% | -$60.9M | 2.75% | 8 |
|
|
2023
Q1 | $381M | Buy |
1,108,261
+129,726
| +13% | +$43.8M | 2.05% | 15 |
|
|
2022
Q4 | $358M | Sell |
978,535
-68,625
| -7% | -$24.3M | 2.24% | 14 |
|
|
2022
Q3 | $339M | Buy |
1,047,160
+63,459
| +6% | +$20.1M | 2.24% | 14 |
|
|
2022
Q2 | $319M | Buy |
983,701
+115,686
| +13% | +$34.7M | 2.1% | 15 |
|
|
2022
Q1 | $249M | Sell |
868,015
-319,727
| -27% | -$82.3M | 1.83% | 18 |
|
|
2021
Q4 | $328M | Sell |
1,187,742
-27,422
| -2% | -$6.95M | 1.83% | 19 |
|
|
2021
Q3 | $281M | Buy |
1,215,164
+24,293
| +2% | +$6M | 1.72% | 20 |
|
|
2021
Q2 | $273M | Buy |
1,190,871
+34,340
| +3% | +$6.9M | 1.66% | 22 |
|
|
2021
Q1 | $216M | Buy |
1,156,531
+5,057
| +0.4% | +$989K | 1.37% | 31 |
|
|
2020
Q4 | $194M | Buy |
1,151,474
+52,169
| +5% | +$7.79M | 1.24% | 32 |
|
|
2020
Q3 | $163M | Sell |
1,099,305
-9,893
| -0.9% | -$1.53M | 1.15% | 36 |
|
|
2020
Q2 | $182M | Buy |
1,109,198
+31,258
| +3% | +$4.8M | 1.37% | 32 |
|
|
2020
Q1 | $150M | Buy |
1,077,940
+71,522
| +7% | +$9.83M | 1.3% | 32 |
|
|
2019
Q4 | $132M | Buy |
1,006,418
+269,860
| +37% | +$31.3M | 0.92% | 38 |
|
|
2019
Q3 | $82.4M | Sell |
736,558
-148,185
| -17% | -$16.5M | 0.6% | 47 |
|
|
2019
Q2 | $98M | Buy |
884,743
+214,787
| +32% | +$25.3M | 0.73% | 43 |
|
|
2019
Q1 | $86.9M | Buy |
669,956
+71,644
| +12% | +$8.71M | 0.8% | 38 |
|
|
2018
Q4 | $69.2M | Buy |
598,312
+406,912
| +213% | +$45.5M | 0.74% | 40 |
|
|
2018
Q3 | $20.5M | Buy |
191,400
+163,091
| +576% | +$16.3M | 0.26% | 71 |
|
|
2018
Q2 | $2.42M | Buy |
28,309
+192
| +0.7% | +$15.8K | 0.03% | 197 |
|
|
2018
Q1 | $2.17M | Sell |
28,117
-1,156
| -4% | -$93.1K | 0.02% | 206 |
|
|
2017
Q4 | $2.47M | Buy |
29,273
+356
| +1% | +$30.3K | 0.03% | 188 |
|
|
2017
Q3 | $2.47M | Sell |
28,917
-250
| -0.9% | -$20.5K | 0.03% | 178 |
|
|
2017
Q2 | $2.4M | Sell |
29,167
-169
| -0.6% | -$13.8K | 0.03% | 171 |
|
|
2017
Q1 | $2.47M | Buy |
29,336
+169
| +0.6% | +$13.5K | 0.03% | 168 |
|
|
2016
Q4 | $2.15M | Sell |
29,167
-11
| -0% | -$819 | 0.03% | 170 |
|
|
2016
Q3 | $2.34M | Sell |
29,178
-46
| -0.2% | -$3.68K | 0.03% | 162 |
|
|
2016
Q2 | $2.3M | Buy |
29,224
+116
| +0.4% | +$8.73K | 0.03% | 160 |
|
|
2016
Q1 | $2.1M | Buy |
29,108
+369
| +1% | +$27.9K | 0.03% | 163 |
|
|
2015
Q4 | $2.42M | Buy |
28,739
+1,526
| +6% | +$127K | 0.03% | 152 |
|
|
2015
Q3 | $2.28M | Buy |
27,213
+674
| +3% | +$56.9K | 0.03% | 161 |
|
|
2015
Q2 | $2.22M | Sell |
26,539
-108
| -0.4% | -$8.23K | 0.03% | 165 |
|
|
2015
Q1 | $1.94M | Buy |
26,647
+1,080
| +4% | +$76.9K | 0.03% | 181 |
|
|
2014
Q4 | $1.76M | Buy |
25,567
+1,107
| +5% | +$74.7K | 0.02% | 182 |
|
|
2014
Q3 | $1.59M | Sell |
24,460
-30,000
| -55% | -$1.9M | 0.02% | 186 |
|
|
2014
Q2 | $3.39M | Sell |
54,460
-138
| -0.3% | -$8.23K | 0.05% | 134 |
|
|
2014
Q1 | $3.21M | Sell |
54,598
-924
| -2% | -$51.6K | 0.05% | 136 |
|
|
2013
Q4 | $2.83M | Sell |
55,522
-3,762
| -6% | -$188K | 0.05% | 144 |
|
|
2013
Q3 | $2.98M | Buy |
59,284
+29
| +0% | +$1.52K | 0.05% | 133 |
|
|
2013
Q2 | $2.91M | Buy |
+59,255
| New | +$3.22M | 0.06% | 131 |
|
Other funds holding LLY
VCM
VPM
Bahl & Gaynor's LLY Position: Q1 2026 in Review
Bahl & Gaynor reduced its Eli Lilly (LLY) stake by 15% in Q1 2026, selling an estimated $123M and leaving 666,129 shares worth $613M. The position accounts for 3.09% of the portfolio, ranked #4.
Bahl & Gaynor first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $846M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Bahl & Gaynor held 666,129 shares of Eli Lilly worth $613M as of Q1 2026.
- Bahl & Gaynor sold 121,251 Eli Lilly shares in Q1 2026, an estimated $123M.
- Eli Lilly made up 3.09% of Bahl & Gaynor's portfolio in Q1 2026, its #4 holding.
- Bahl & Gaynor first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
- Bahl & Gaynor's Eli Lilly position peaked at $846M in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Bahl & Gaynor's 13F filing for Q1 2026, filed 7 May 2026.